The results showed that E-cadherin (an epithelial marker) was expressed at extremely low levels in both glioma cell lines, whereas it was significantly upregulated after treatment with SKF96365 for 3 h (Figure 3C), suggesting a shift towards epithelial phenotype. The gene discussed is CDH1; the disease is central nervous system cancer.